Total Payments
$17,138
2024 Payments
$399.37
Companies
53
Transactions
1,217
Medicare Patients
5,609
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$16,217 (94.6%)
Travel$535.18 (3.1%)
Other$345.30 (2.0%)
Education$22.72 (0.1%)
Gifts$17.28 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,217 | 1,192 | 94.6% |
| Travel and Lodging | $535.18 | 1 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $345.30 | 19 | 2.0% |
| Education | $22.72 | 4 | 0.1% |
| Gift | $17.28 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $2,466 | 233 | $0 (2023) |
| ABBVIE INC. | $1,678 | 107 | $0 (2024) |
| Biogen, Inc. | $1,185 | 101 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,082 | 62 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $966.61 | 73 | $0 (2021) |
| UCB, Inc. | $887.97 | 57 | $0 (2024) |
| Allergan, Inc. | $828.20 | 81 | $0 (2022) |
| GENZYME CORPORATION | $688.74 | 40 | $0 (2022) |
| Amgen Inc. | $666.40 | 34 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $571.25 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $399.37 | 19 | PFIZER INC. ($77.16) |
| 2023 | $2,019 | 126 | Teva Pharmaceuticals USA, Inc. ($408.10) |
| 2022 | $3,081 | 177 | ABBVIE INC. ($999.31) |
| 2021 | $2,844 | 206 | Teva Pharmaceuticals USA, Inc. ($474.30) |
| 2020 | $2,352 | 161 | Allergan, Inc. ($344.74) |
| 2019 | $2,345 | 186 | Teva Pharmaceuticals USA, Inc. ($476.99) |
| 2018 | $2,387 | 175 | Sunovion Pharmaceuticals Inc. ($323.34) |
| 2017 | $1,711 | 167 | GENZYME CORPORATION ($176.78) |
All Payment Transactions
1,217 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $44.63 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Neurology | ||||||
| 09/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: PAIN | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/29/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.43 | General |
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Neurology | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PAIN | ||||||
| 07/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: PAIN | ||||||
| 07/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: PAIN | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Neurology | ||||||
| 12/08/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Central Nervous System | ||||||
| 12/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Central Nervous System | ||||||
| 12/05/2023 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS, EXSERVAN | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 991 | 32,206 | $696,497 | $244,201 |
| 2022 | 22 | 1,042 | 32,292 | $701,404 | $248,462 |
| 2021 | 29 | 1,133 | 41,535 | $837,160 | $300,741 |
| 2020 | 50 | 2,443 | 45,157 | $1.0M | $339,852 |
Total Patients
5,609
Total Services
151,190
Medicare Billing
$1.1M
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 50 | 30,788 | $369,456 | $148,623 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 343 | $74,865 | $29,014 | 38.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 104 | 180 | $42,840 | $13,628 | 31.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 34 | 99 | $39,996 | $11,408 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $29,310 | $9,957 | 34.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 53 | 53 | $33,443 | $8,285 | 24.8% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 22 | 22 | $18,854 | $4,897 | 26.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 21 | 21 | $15,519 | $3,929 | 25.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 22 | 22 | $11,440 | $2,934 | 25.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 25 | 46 | $7,820 | $2,205 | 28.2% |
| 95926 | Placement of skin electrodes and measurement of stimulated sites in legs | Facility | 2023 | 52 | 77 | $19,096 | $1,569 | 8.2% |
| 95925 | Placement of skin electrodes and measurement of stimulated sites in arms | Facility | 2023 | 47 | 62 | $15,376 | $1,332 | 8.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 14 | 14 | $5,530 | $1,303 | 23.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 29 | 29 | $4,582 | $1,222 | 26.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 126 | 154 | $1,232 | $1,202 | 97.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,134 | $1,111 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $1,860 | $636.81 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 41 | $2,050 | $449.77 | 21.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $340.00 | $333.20 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 13 | $754.00 | $118.95 | 15.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 14 | 100 | $1,000 | $42.94 | 4.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 51 | 30,900 | $370,800 | $148,661 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 203 | 317 | $65,619 | $27,686 | 42.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 106 | 166 | $39,508 | $12,751 | 32.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 79 | 79 | $49,849 | $12,714 | 25.5% |
About Dr. Christopher Vanderzant, DO
Dr. Christopher Vanderzant, DO is a Neurological Surgery healthcare provider based in San Angelo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285616391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Vanderzant, DO has received a total of $17,138 in payments from pharmaceutical and medical device companies, with $399.37 received in 2024. These payments were reported across 1,217 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($16,217).
As a Medicare-enrolled provider, Vanderzant has provided services to 5,609 Medicare beneficiaries, totaling 151,190 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Location San Angelo, TX
- Active Since 11/15/2005
- Last Updated 07/09/2007
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1285616391
Products in Payments
- UBRELVY (Drug) $1,120
- AJOVY (Biological) $829.17
- NURTEC ODT (Drug) $804.63
- TYSABRI (Biological) $744.52
- APTIOM (Drug) $711.05
- Aimovig (Biological) $648.43
- AJOVY (Drug) $634.04
- Briviact (Drug) $631.99
- AUBAGIO (Drug) $611.72
- AUSTEDO (Drug) $586.67
- BOTOX (Biological) $576.00
- NUPLAZID (Drug) $452.59
- QULIPTA (Drug) $338.72
- OXTELLAR XR (Drug) $335.81
- AIMOVIG (Biological) $335.38
- NORTHERA (Drug) $333.84
- Xyrem (Drug) $330.34
- KESIMPTA (Drug) $295.02
- Austedo XR (Drug) $253.62
- RYTARY (Drug) $253.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurological Surgery Doctors in San Angelo
Luis Duarte, Md, MD
Neurological Surgery — Payments: $1.4M
Neurological Surgery $1.4M
Dr. Joseph Hobbs, M.d, M.D
Neurological Surgery — Payments: $7,749
Neurological Surgery $7,749
Dr. Amon Zakeri, Md, MD
Neurological Surgery — Payments: $2,048
Neurological Surgery $2,048
Leslie Hutchins, Md, MD
Neurological Surgery — Payments: $1,378
Neurological Surgery $1,378
Timothy Hopkins, Md, MD
Neurological Surgery — Payments: $295.49
Neurological Surgery $295.49
Mr. Duncan Fischer, Md Phd, MD PHD
Neurological Surgery — Payments: $179.32
Neurological Surgery $179.32